LARGE; Charles
Patent Applications and Registrations
Patent applications and USPTO patent grants for LARGE; Charles.The latest application filed is for "modulators of kv3 channels to treat pain".
- LARGE; Charles - Stevenage GB
- Large; Charles - Verona IT
| Patent | Date |
|---|---|
| Modulators Of Kv3 Channels To Treat Pain App 20220071998 - LARGE; Charles ; et al. | 2022-03-10 |
| Hydantoin Derivatives Useful As Kv3 Inhibitors App 20220054490 - Alvaro; Giuseppe ; et al. | 2022-02-24 |
| Hydantoin derivatives useful as Kv3 inhibitors Grant 11,197,859 - Alvaro , et al. December 14, 2 | 2021-12-14 |
| Modulators of KV3 channels to treat pain Grant 11,147,813 - Large , et al. October 19, 2 | 2021-10-19 |
| Hydantoin Derivatives Useful As Kv3 Inhibitors App 20200360379 - ALVARO; Giuseppe ; et al. | 2020-11-19 |
| Imidazolidinedione Derivatives App 20200163964 - ALVARO; Giuseppe ; et al. | 2020-05-28 |
| Imidazolidinedione derivatives Grant 10,632,118 - Alvaro , et al. | 2020-04-28 |
| Hydantoin Derivatives Useful As Kv3 Inhibitors App 20190192516 - ALVARO; Giuseppe ; et al. | 2019-06-27 |
| Hydantoin derivatives useful as Kv3 inhibitors Grant 10,265,316 - Alvaro , et al. | 2019-04-23 |
| Modulators Of Kv3 Channels To Treat Pain App 20190000848 - LARGE; Charles ; et al. | 2019-01-03 |
| Imidazolidinedione Derivatives App 20180338974 - ALVARO; Giuseppe ; et al. | 2018-11-29 |
| Imidazolidinedione derivatives Grant 10,058,551 - Alvaro , et al. August 28, 2 | 2018-08-28 |
| Imidazolidinedione Derivatives App 20180021336 - ALVARO; Giuseppe ; et al. | 2018-01-25 |
| Imidazolidinedione derivatives Grant 9,849,131 - Alvaro , et al. December 26, 2 | 2017-12-26 |
| Hydantoin Derivatives Useful As Kv3 Inhibitors App 20170273981 - ALVARO; Giuseppe ; et al. | 2017-09-28 |
| Hydantoin derivatives as Kv3 inhibitors Grant 9,669,030 - Large June 6, 2 | 2017-06-06 |
| Imidazolidinedione Derivatives App 20170065585 - ALVARO; Giuseppe ; et al. | 2017-03-09 |
| Hydantoin Derivatives Useful As Kv3 Inhibitors App 20160251340 - ALVARO; Giuseppe ; et al. | 2016-09-01 |
| Hydantoin derivatives useful as Kv3 inhibitors Grant 9,346,790 - Alvaro , et al. May 24, 2 | 2016-05-24 |
| Imidazolidinedione Derivatives App 20160058737 - ALVARO; Giuseppe ; et al. | 2016-03-03 |
| Imidazolidinedione derivatives Grant 9,216,967 - Alvaro , et al. December 22, 2 | 2015-12-22 |
| Hydantoin Derivatives As Kv3 Inhibitors App 20150157631 - Large; Charles | 2015-06-11 |
| Imidazolidinedione Derivatives App 20150018377 - ALVARO; Giuseppe ; et al. | 2015-01-15 |
| Imidazolidinedione derivatives Grant 8,722,695 - Alvaro , et al. May 13, 2 | 2014-05-13 |
| Hydantoin Derivatives Useful As Kv3 Inhibitors App 20130267510 - Alvaro; Giuseppe ; et al. | 2013-10-10 |
| Imidazolidinedione Derivatives App 20120289526 - Alvaro; Giuseppe ; et al. | 2012-11-15 |
| Pharmaceutical compositions comprising 2-methoxy-5-(5-trifluoromethyl-tetrazol-1-yl-benzyl)-(2S-phenylpiperidin-- 3S-yl-) Grant 8,093,268 - Alvaro , et al. January 10, 2 | 2012-01-10 |
| Pharmaceutical Compositions Comprising 2-methoxy-5-(5-trifluoromethyl-tetrazol-1-yl-benzyl)-(2s-phenylpiperidin-- 3s-yl-) App 20100113521 - Alvaro; Giuseppe ; et al. | 2010-05-06 |
| Pharmaceutical Compositions Comprising 3,5-diamino-6-(2,3-dichlophenyl)-1,2,4-triazine Or R(-)-2,4-diamino-5-(2,3-dichlorophenyl)-6-fluoromethyl Pyrimidine And An Nk1 App 20100105688 - Alvaro; Giuseppe ; et al. | 2010-04-29 |
| Pharmaceutical Compositions Comprising Nk1 Receptor Antagonists And Sodium Channel Blockers App 20090326032 - Alvaro; Giuseppe ; et al. | 2009-12-31 |
| Pharmaceutical Compositions Comprising Nk1 Receptor Antagonists And Sodium Channel Blockers App 20090318530 - Alvaro; Giuseppe ; et al. | 2009-12-24 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 